Liposome-mediated NGF gene transfection following neuronal injury: Potential therapeutic applications

Gene Therapy

Volumn 6, Issue 6, 1999, Pages 994-1005

  Zou, L L ^a,b   Huang, L ^c   Hayes, R L ^d   Black, C ^d   Qiu, Y H ^d   Perez Polo, J R ^e   Le, W ^a   Clifton, G L ^d   Yang, K ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

ChAT; CNS; Gene therapy; Liposomes; Neuronal injury; NGF

Indexed keywords

CATION; CHOLESTEROL; LIPOSOME; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC TRANSFECTION; HIPPOCAMPUS; NERVE INJURY; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN INJURIES; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; GENE THERAPY; HIPPOCAMPUS; LIPOSOMES; NERVE GROWTH FACTORS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

ANIMALIA;

EID: 0033020604     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300936     Document Type: Article

References (64)

1. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transactions. J Neurosci 1986; 8: 2155-2162.
2. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987; 235: 214-216.
3. Williams LR et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc Natl Acad Sci USA 1986; 83: 9231-9235.
4. Rosenberg MB et al. Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 1988; 242: 1575-1578.
5. Hagg T, Varon S. Neurotropism of nerve growth factor for adult rat septal cholinergic axons in vivo. Exp Neurol 1993; 119: 37-45.
6. Fischer W, Bjorklund A, Chen K, Gage FH. NGF improves spatial memory in aged rodents as a function of age. J Neurosci 1991; 11: 1889-1906.
7. Fischer W, Bjorklund A. Loss of AchE and NGFr-labeling precedes neuronal death of axotomized septodiagonal band neurons: reversal by intraventricular NGF infusion. Exp Neurol 1991; 113: 93-108.
8. Rylett RJ, Goddard S, Schmidt BM, Williams LR. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. J Neurosci 1993; 13: 3956-3963.
9. Dekker AJ, That L. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements. Brain Res 1992; 584: 55-63.
10. Dekker AJ, Ray WJ, Tha LJ, Gage FH. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 1994; 60: 299-309.
11. Dixon CE et al. Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp Neurol 1997; 146: 479-490.
12. McDermott KL et al. Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat. J Neurotrauma 1997; 14: 191-198.
13. Lawrence MS et al. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 1996; 16: 486-496.
14. Lawrence MS et al. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab 1997; 17: 740-744.
15. Yoon SO et al. Adenovirus-mediated gene delivery into neuronal precursors of the adult mouse brain. Proc Natl Acad Sci USA 1996; 93: 11974-11979.
16. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
17. Naldini L et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382-11388.
18. Karpati G, Lochmuller H, Nalbantoglu J, Durham H. The principles of gene therapy for the nervous system. Trends Neurosci 1996; 19: 49-54.
19. Castel-Barthe MN et al. Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: effect on basal forebrain cholinergic neurons during aging. Neurobiol Dis 1996; 3: 76-86.
20. Choi-Lundberg DL et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 1997; 275: 838-841.
21. Baumgartner BJ, Shine HD. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 1997; 17: 6504-6511.
22. Yang GY, Zhao YJ, Davidson BL, Betz AL. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 1997; 751: 181-188.
23. Feigner PL et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7417.
24. Feigner PL. Improvements in cationic liposomes for in vivo gene transfer. Hum Gene Ther 1996; 7: 1791-1793.
25. Nabel GL. Direct gene transfer with DNA liposome complexes in melanoma: expression, biological activity, lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90: 11307-11311.
26. Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-211.
27. Roessler B, Davidson BL. Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. Neurosci Lett 1994; 167: 5-10.
28. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Therapy 1995; 2: 710-722.
29. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Therapy 1997; 4: 891-900.
30. Yang K, Clifton GL, Hayes RL. Gene therapy for central nervous system injury: the use of cationic liposomes: an invited review. J Neurotrauma 1997; 14: 281-297.
31. McIntosh TK, Juhler M, Wieloch T. Novel pharmacological strategies in the treatment of experimental traumatic brain injury: 1998. J Neurotrauma 1998; 15: 731-769.
32. Le W et al. Liposome-mediated NGF gene transfection increases ChAT activity in rat septo-hippocampal cell cultures. NeuroReport 1996; 7: 710-712.
33. Yang K et al. DC-Chol liposome-mediated gene transfer in rat spinal cord. NeuroReport 1997; 8: 2355-2358.
34. Yang K et al. Optimizing liposome-mediated gene transfer in primary rat septo-hippocampal cell cultures. Neurosci Lett 1994; 182: 287-290.
35. Whitson JS et al. Brief potassium depolarization decreases neurofilament proteins in CNS culture. Brain Res 1995; 694: 213-222.
36. Suhr ST, Gage FH. Gene therapy for neurologic disease. Arch Neurol 1993; 50: 1252-1268.
37. Doran SE et al. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery 1995; 36: 965-970.
38. Thorsell A, Lomqvist AG, Heilig M. Cationic lipid-mediated delivery and expression of prepro-neuropeptide Y cDNA after intraventricular administration in rat: feasibility and limitations. Reg Pept 1996; 61: 205-211.
39. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1995; 1: 39-46.
40. Fasbender A et al. Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo. Gene Therapy 1997; 4: 716-725.
41. Hayes RL et al. Rescue of injury-induced loss by BDNF gene transfection in primary septo-hippocampal cell cultures. Neurosci Lett 1995; 191: 121-125.
42. Frick KM, Price DL, Koliatsos VE, Markowska AL. The effects of nerve growth factor on spatial recent memory in aged rats persist after discontinuation of treatment. J Neurosci 1997; 17: 2543-2550.
43. Martinez-Serrano A, Hantzopoulos PA, Bjorklund A. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons. Eur J Neurosci 1996; 8: 727-735.
44. Sinson G, Voddi M, McIntosh TK. Nerve growth factor administration attenuates cognitive but not neurobehavioral motor dysfunction or hippocampal cell loss following fluid-percussion brain injury in rats. J Neurochem 1995; 65: 2209-2216.
45. Sinson G, Voddi M, McIntosh TK. Combined fetal neural transplantation and nerve growth factor infusion: effects on neurological outcome following fluid-percussion brain injury in the rat. J Neurosurg 1996; 84: 665-662.
46. Batchelor PE et al. Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: response to fimbria-fornix transection. J Comp Neurol 1989; 284: 187-204.
47. Winn SR et al. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 1994; 91: 2324-2328.
48. Alderson RF, Alterman AL, Barde YA, Lindsay RM. Brain derived neurotrophic factor increases survival and differentiated functions of rat sepral cholinergic neurons. Neuron 1990; 5: 297-306.
49. Scali C et al. Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. Neurosci Lett 1994; 170: 117-120.
50. Tuszynski MH, Gage FH. Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery. Proc Natl Acad Sci USA 1995; 92: 4621-4625.
51. Tuszynsk MH, Roberts J, Senut M-C, Gage FH. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Therapy 1996; 3: 305-314.
52. Roner S et al. Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion. J Neurosci Res 1996; 45: 40-56.
53. Imaoka T, Date I, Ohmoto T, Nagatsu T. Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex. Hum Gene Ther 1998; 9: 1093-1102.
54. Zhang LX, Wu M, Han JS. Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vector. NeuroReport 1992; 3: 700-702.
55. Zhang LX et al. Lipofectin-facilitated transfer of cholecystokinin gene corrects behavioral abnormalities of rats with audiogenic seizures. Neuroscience 1997; 77: 15-22.
56. Yang K et al. Liposome-mediated NGF gene transfection increases phosphorylated neurofilament proteins. Mol Brain Res 1996; 43: 13-20.
57. Qiu YH et al. Activation of phosphatidylinositol 3 kinase by BDNF gene transfection in septo-hippocampal cultures. J Neurosci Res 1998; 52: 192-200.
58. Banker GA, Cowan WM. Rat hippocampal neurons in dispersed cell culture. Brain Res 1977; 126: 397-425.
59. Brewer GJ, Cotman CW. Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res 1989; 494: 65-74.
60. Yang K et al. Sustained expression of functional nerve growth factor in primary septohippocampal cell cultures by liposome-mediated gene transfer. Neurosci Lett 1994; 182: 291-294.
61. Yang K et al. In vitro studies of liposome-mediated gene transfection. In: Perez-Polo JR (ed). Paradigms in Neural Injury. Academic Press: San Diego, 1995, pp 290-297.
62. Dixon CE et al. A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Meth 1991; 39: 253-262.
63. Iwamoto Y et al. BDNF cDNA following liposome-mediated gene transfer in intact and traumatically injured rat brain. NeuroReport 1996; 7: 609-612.
64. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to NGF. Proc Natl Acad Sci USA 1976; 73: 2424-2428.